Clinical Trial Update: A Safety and Immune Response Study of 2 Experimental HIV Vaccines [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update describing safety and immune response of two experimental HIV vaccines; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-10-19